# Therapeutic Efficacy in Women With Stress Urinary Incontinence

> **NCT05677295** · PHASE3 · UNKNOWN · sponsor: **Far Eastern Memorial Hospital** · enrollment: 90 (estimated)

## Conditions studied

- Women With Stress Urinary Incontinence

## Interventions

- **DRUG:** duloxetine
- **DRUG:** Imipramine

## Key facts

- **NCT ID:** NCT05677295
- **Lead sponsor:** Far Eastern Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-04-18
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2023-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05677295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05677295, "Therapeutic Efficacy in Women With Stress Urinary Incontinence". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05677295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*